Most commonly, the only actionable lab on the day of exposure is a rapid HIV test from the source-patient (for consideration of PEP)
Less severe percutaneous exposures are associated with solid and blunt tip needles
More severe percutaneous exposures are associated with deep punctures, large bore hollow needles, visible<unk>  on the device, and needles used in patients arteries and veins.
Smaller volume (few drops) exposures are considered to be lower risk than higher volume (major<unk>  splash) for mucous membranes and non-intact skin exposures.
Most<unk>  exposures to HIV are not associated with transmission.
Rapid HIV
Consider hepatitis panel and possibly RPR
Hepatitis B and C infectivity of source patient:
HBs-Ag (active infection)
HBc-Ab IgM (window period)
HepC-Ab, plus or minus viral load
Hepatitis B and C infectivity of source patient:
HBs-Ag (active infection)
HBc-Ab IgM (window period)
HepC-Ab, plus or minus viral load
HBs-Ag (active infection)
HBc-Ab IgM (window period)
HepC-Ab, plus or minus viral load
In some systems, NO immediate laboratory testing is performed
In many systems, a standardized baseline lab panel is sent in the ED and then followed up at employee health the next day
If giving HIV PEP:
Rapid HIV (to confirm they do not already have HIV)
CBC, C7, LFTs, pregnancy test
Rapid HIV (to confirm they do not already have HIV)
CBC, C7, LFTs, pregnancy test
Healthcare occupational exposure to blood or other body fluids
Laceration
Environmental exposure antibiotics
Retained foreign body
Bacteremia vs contaminated blood cultures
Skin and soft tissue infections
Multisystem inflammatory syndrome in children
Combative patient